NL
DE
23 November 2017
Elke de Jong and Joost Schalkwijk received, in collaboration with the Sint Maartenskliniek (Mark Wenink, Elien Mahler) and the department of medical immunology Radboudumc (Hans Koenen), a grant from the Radboudumc regional PhD fund for the research proposal “From psoriasis to arthritis: Improved Detection, characterization and Early treatment of Psoriatic Arthritis (IDE-PsA)” .
In 2016 the department started a study to investigate the dose decrease of biologics for psoriasis, supported by Zonmw (Elke de Jong, Juul van den Reek, Wietske Kievit). In October 2017, Elke de Jong was awarded a grant to implement these results in the Radboudumc by the VGZ ‘Betaald Beter’ project.
Recently awarded to Elke de Jong, department of Dermatology, and collegues.
Elke de Jong and Joost Schalkwijk received, in collaboration with the Sint Maartenskliniek (Mark Wenink, Elien Mahler) and the department of medical immunology Radboudumc (Hans Koenen), a grant from the Radboudumc regional PhD fund for the research proposal “From psoriasis to arthritis: Improved Detection, characterization and Early treatment of Psoriatic Arthritis (IDE-PsA)” .
In 2016 the department started a study to investigate the dose decrease of biologics for psoriasis, supported by Zonmw (Elke de Jong, Juul van den Reek, Wietske Kievit). In October 2017, Elke de Jong was awarded a grant to implement these results in the Radboudumc by the VGZ ‘Betaald Beter’ project.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Large NWA ORC grant awarded for national skin research: Next Generation ImmunoDermatology
23 March 2022Research for better treatment methods for chronic skin diseases.
read more
VWS report on AI and describes added value of MonitAir app
1 February 2022 The report Social costs and benefits of Artificial Intelligence in healthcare from the Dutch Ministry of Health, Welfare and Sport was published. The researchers were positive about the smart app MonitAir, which was partly developed by Primary and Community Care of the Radboudumc. read more
Radboudumc does large-scale research on systemic sclerosis
10 September 2020 In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases. read more
Tight controlled dose reduction of biologics in psoriasis patients
7 May 2020 Published in JAMA Dermatology, RIHS researcher Selma Atalay and colleagues investigated in a randomized controlled trial a tight controlled dose reduction strategy of the biologics adalimumab, etanercept and ustekinumab in psoriasis patients. read more
First BeNeFit funding granted for psoriasis
17 January 2020 RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis. read more
New drugs available more quickly for the right patient
12 January 2017Wietske Kievit and Floor Berden have illustrated this in PlosOne paper
read more